GLP-1 Receptor Agonist Use, Chronic Kidney Disease Risk, & Type 2 Diabetes
About this video
Advanced · Editorial review · 85% confidenceNew channel Mayo Proceedings: title sample judged 'pick' (Nearly every upload is a concise research-summary explainer of peer-reviewed clinical findings presented by Mayo Clinic ); passed a second screen for sellers/exam-prep/re-uploads; 3 of 3 sampled transcripts showed teaching, 0 not; titles picked one by one, checked strictly; oEmbed verified.
A 9-minute video from Mayo Proceedings: “GLP-1 Receptor Agonist Use, Chronic Kidney Disease Risk, & Type 2 Diabetes”.
Video by Mayo Proceedings, played through YouTube's embedded player.